🇺🇸 FDA
Patent

US 7056908

Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors

granted A61KA61K31/40A61K31/70

Quick answer

US patent 7056908 (Pharmaceutical compositions and methods for preventing skin tumor formation and causing regression of existing tumors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/40, A61K31/70, A61P, A61P35/00